Upcoming Webinars

The goal of this webinar is to share the learnings around the ease of onboarding a liquid biopsy solution in a laboratory setting

In this webinar, Dr. Jantus-Lewintre shares her lab's experience evaluating the Oncomine Comprehensive Assay Plus

In their retrospective study Integra Connect investigated how this behavior affects outcomes.

In this Bionano in Motion webinar, we explore the utility and validity of an innovative strategy, proposed by Dr Brandes from Heinrich-Heine University and University Hospital Dusseldorf that combines Optical Genome Mapping (OGM) and whole exome sequencing (WES) in 60 HD and ETV6::RUNX1+ BCP-ALL cases. This study shows that OGM detected a high number of additional SVs not identified using the conventional methods, including (subclonal) IKZF1 deletions, a prognostically relevant subtype.

In this Bionano in Motion webinar, we explore the utility and validity of an innovative strategy, proposed by Dr. Kolhe’s lab, from Augusta University, that combines optical genome mapping (OGM) with a comprehensive 523-gene next-generation sequencing (NGS) panel. This unique approach was meticulously evaluated against more traditional methods including karyotyping, fluorescent in situ hybridization (FISH), and a 54-gene NGS panel.

We are thrilled to invite you to our upcoming online webinar, where we will delve into groundbreaking research on the spatial organization of immune cells in human tumors and its impact on immunotherapy outcomes.

In this webinar, Dr Federico Cappuzzo will speak about clinical implications of liquid biopsy-based CGP for lung cancer patients, discussing current clinical evidence and sharing his vision on future applications.

Join Illumina and Parse Biosciences for a webinar where our invited speaker will present results of his recent single-cell study.

Immune therapy has emerged as the new frontier of cancer treatment.

Roche Tissue Diagnostics invites you to learn more about the importance of identifying each level of HER2 expression.

In this webinar we will discuss the use of the PhenoImager HT (Akoya Biosciences) platform to dissect the immune microenvironment of low-grade early-stage endometrial carcinomas.

From the European Society of Medical Oncology (ESMO) 2022 Conference in Paris, a roundtable discussion on the clinical impact of Comprehensive Genomic Profiling.